Markus Axelsson
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: January 17, 2026
Cerebrospinal fluid alpha-internexin concentrations measured in patients with Guillain-Barré syndrome: a possible prognostic biomarker for disability at 12 months.
Journal: Journal of neurology
Published: January 16, 2026
Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple Sclerosis.
Journal: European journal of neurology
Published: January 09, 2026
Lymphocyte Dynamics and the Emergence of Secondary Autoimmunity Following Immune Reconstitution Therapies in Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 17, 2025
A novel multiplexed biomarker panel reveals key molecular pathways in progressive multiple sclerosis.
Journal: Brain communications
Published: October 02, 2025
Non-physiological potassium concentrations in commercial culture media trigger acute seizure-like activity in human iPSC-derived neurons.
Journal: Scientific reports
Published: September 20, 2025
Blood biomarkers of seizures in epilepsy: machine learning reveals altered plasma proteome.
Journal: BMJ neurology open
Published: August 14, 2025
Validation of a plasma GFAP immunoassay and establishment of age-related reference values: bridging analytical performance and routine implementation.
Journal: Clinical chemistry and laboratory medicine
Published: July 11, 2025
The Effect of Gadolinium on Synthetic Magnetic Resonance Quantitative Imaging.
Journal: Journal of neuroimaging : official journal of the American Society of Neuroimaging
Published: June 23, 2025
Plateau of practice effects and noise with repeat SDMT testing in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 31, 2025
Quality of life is decreased in persons with relapsing-remitting multiple sclerosis experiencing progression independent of relapse activity.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 18, 2025
Last Updated: 09/26/2026